23136-18-7 Usage
Uses
Used in Pharmaceutical Industry:
1-[2-(3-BROMOPHENOXY)ETHYL]-PYRROLIDINE is used as a precursor in the synthesis of new drugs for its potential to contribute to the development of biologically active molecules with therapeutic applications.
Used in Chemical and Biological Research:
1-[2-(3-BROMOPHENOXY)ETHYL]-PYRROLIDINE is used as a research tool in chemical and biological studies, facilitating the exploration of its properties and potential interactions with other molecules for various scientific inquiries.
Used in Organic Synthesis:
1-[2-(3-BROMOPHENOXY)ETHYL]-PYRROLIDINE is used as a key intermediate in organic synthesis, enabling the creation of a wide range of compounds with diverse applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 23136-18-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,1,3 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 23136-18:
(7*2)+(6*3)+(5*1)+(4*3)+(3*6)+(2*1)+(1*8)=77
77 % 10 = 7
So 23136-18-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H16BrNO/c13-11-4-3-5-12(10-11)15-9-8-14-6-1-2-7-14/h3-5,10H,1-2,6-9H2
23136-18-7Relevant articles and documents
1H-PYRROLO[2,3-B] PYRIDINE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS
-
Paragraph 0400, (2015/02/18)
The inventions relates to compounds of (I) and therapeutic uses thereof: (I) The terms Z, Y, and R1 are as defined in the claims.
1H-PYRROLO[2,3-B] PYRIDINE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS
-
Page/Page column 92, (2013/08/15)
The inventions relates to compounds of (I) and therapeutic uses thereof : (I) The terms Z, Y, and R1 are as defined in the claims.
PYRIMIDINE COMPOUNDS AND METHODS OF USE
-
Page/Page column 92, (2010/11/24)
The invention provides pyrimidine compounds having formula (A): The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, and various other specific receptor and non-receptor kinases.
Benzotriazine inhibitors of kinases
-
Page/Page column 49, (2008/06/13)
The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.